COVFIS2021: Efficacy of Respiratory Rehabilitation After COVID-19 Severe Infection
Study Details
Study Description
Brief Summary
The purpose of this study is to investigate the effects of a training program in patients that have suffered a COVID infection
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Once patients have been selected and meet inclusion criteria, they will sign informed consent. They will make a first visit to obtain the basal parameters. Once done, they will start the individualized training program for 12 weeks 3 times a week.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Training program Global intervallic exercise using cyclometer and analytical strength exercises |
Other: Interval training + analytical strength
Patients will receive a training program
|
Experimental: Training program + Inspiratory muscle traioning (IMT) Global intervallic exercise using cyclometer and analytical strength exercises + inspiratory muscles training |
Other: Interval training + analytical strength and IMT
Patients will receive a training program + IMT
|
Outcome Measures
Primary Outcome Measures
- changes in walking distance in the 6 minutes walk test [Baseline and 12 weeks after]
6MWT is a submaximal test performed in 30 meters corridor.
Secondary Outcome Measures
- changes in the maximum watts generated [Baseline and 12 weeks after]
Cardiopulmonary exercise test will be performed as maximal test
- changes in (oxygen consumption) VO2 max [Baseline and 12 weeks after]
Cardiopulmonary exercise test will be performed as maximal test
- changes in peak VO2 [Baseline and 12 weeks after]
Cardiopulmonary exercise test will be performed as maximal test
- changes in the diaphragmatic path [Baseline and 12 weeks after]
Diaphragm echocardiography will be performed
- changes in diaphragm thickness [Baseline and 12 weeks after]
Diaphragm echocardiography will be performed
- changes in diaphragmatic shortening [Baseline and 12 weeks after]
Diaphragm echocardiography will be performed
- changes in dyspnea [Baseline and 12 weeks after]
Measured with mMRC scale (scores from 0-4)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Men and women ≥18 years
-
Patients discharged from the Pulmonology Service with a diagnosis of COVID-19 by positive PCR and with severe pneumonia.
-
At least three months after the presence of at least one of the following criteria:
-
MRC dyspnea greater than or equal to 2.
-
Decrease in the meters walked with respect to the reference values in the 6-minute walking test.
- Decreased respiratory muscle strength measured at Maximum Inspiratory Pressure (PIM) and / or Maximum Expiratory Pressure (PEM) with respect to reference values.
- Sign informed consent from the study
Exclusion Criteria:
-
Patients who do not want to be included in the study.
-
Pregnant women.
-
Impossibility to perform ergometry or ultrasound.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Josep Trueta University Hospital | Girona | Spain | 17007 |
Sponsors and Collaborators
- Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Investigators
- Principal Investigator: Gerard Muñoz, PhD, Girona Biomedical Research Institute
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- COVFIS2021